March 2, 2015 – BOSTON, MA and TARRYTOWN, New York. – Resilience Therapeutics, Inc. (Resilience) and PGI Drug Discovery LLC (PsychoGenics), today announced that they have entered into a partnership to discover and optimize novel treatments for Post-Traumatic Stress Disorder (PTSD) and related conditions.